Wirden M - Search Results

1

Usefulness of an HIV DNA resistance genotypic test in patients who are candidates for a switch to the rilpivirine/emtricitabine/tenofovir disoproxil fumarate combination.

Lambert-Niclot S, Allavena C, Grude M, Flandre P, Sayon S, Andre E, Wirden M, Rodallec A, Jovelin T, Katlama C, Calvez V, Raffi F, Marcelin AG. Lambert-Niclot S, et al. Among authors: wirden m. J Antimicrob Chemother. 2016 Aug;71(8):2248-51. doi: 10.1093/jac/dkw146. Epub 2016 May 26. J Antimicrob Chemother. 2016. PMID: 27231280

2

Effects of cyclosporine and hydrocortisone on Kaposi's sarcoma-associated herpesvirus genome replication and cell apoptosis induction.

Marcelin AG, Milliancourt C, Dupin N, Wirden M, Huraux JM, Agut H, Calvez V. Marcelin AG, et al. Among authors: wirden m. Transplantation. 2001 Nov 27;72(10):1700-3. doi: 10.1097/00007890-200111270-00023. Transplantation. 2001. PMID: 11726836

3

Impact of discrepancies between the Abbott realtime and cobas TaqMan assays for quantification of human immunodeficiency virus type 1 group M non-B subtypes.

Wirden M, Tubiana R, Marguet F, Leroy I, Simon A, Bonmarchand M, Ait-Arkoub Z, Murphy R, Marcelin AG, Katlama C, Calvez V. Wirden M, et al. J Clin Microbiol. 2009 May;47(5):1543-5. doi: 10.1128/JCM.02134-08. Epub 2009 Mar 18. J Clin Microbiol. 2009. PMID: 19297599 Free PMC article.

4

Pharmacokinetics, protein-binding-adjusted inhibitory quotients for atazanavir/ritonavir 300/100 mg in treatment-naïve HIV-infected patients.

Lambert-Niclot S, Machouf N, Peytavin G, Soulie C, Wirden M, Simon A, Murphy RL, Katlama C, Thomas R, Calvez V, Marcelin AG. Lambert-Niclot S, et al. Among authors: wirden m. HIV Med. 2010 Nov;11(10):666-9. doi: 10.1111/j.1468-1293.2010.00839.x. HIV Med. 2010. PMID: 20497253 Free article.

5

Upgraded Cobas Ampliprep-Cobas TaqMan version 2.0 HIV-1 RNA quantification assay versus first version: correction of underestimations.

Wirden M, Tubiana R, Fourati S, Thevenin M, Simon A, Canestri A, Ait-Arkoub Z, Soulie C, Marcelin AG, Katlama C, Calvez V. Wirden M, et al. J Clin Microbiol. 2011 Jul;49(7):2700-2. doi: 10.1128/JCM.00061-11. Epub 2011 May 4. J Clin Microbiol. 2011. PMID: 21543582 Free PMC article.

6

Resistance profiles of emtricitabine and lamivudine in tenofovir-containing regimens.

Marcelin AG, Charpentier C, Wirden M, Landman R, Valantin MA, Simon A, Katlama C, Yeni P, Descamps D, Aubron-Olivier C, Calvez V. Marcelin AG, et al. Among authors: wirden m. J Antimicrob Chemother. 2012 Jun;67(6):1475-8. doi: 10.1093/jac/dks047. Epub 2012 Feb 26. J Antimicrob Chemother. 2012. PMID: 22371439

7

Prevalence of pre-existing resistance-associated mutations to rilpivirine, emtricitabine and tenofovir in antiretroviral-naive patients infected with B and non-B subtype HIV-1 viruses.

Lambert-Niclot S, Charpentier C, Storto A, Fofana DB, Soulié C, Fourati S, Visseaux B, Wirden M, Morand-Joubert L, Masquelier B, Flandre P, Calvez V, Descamps D, Marcelin AG. Lambert-Niclot S, et al. Among authors: wirden m. J Antimicrob Chemother. 2013 Jun;68(6):1237-42. doi: 10.1093/jac/dkt003. Epub 2013 Jan 29. J Antimicrob Chemother. 2013. PMID: 23361642

8

Genetic barrier to the development of resistance to rilpivirine and etravirine between HIV-1 subtypes CRF02_AG and B.

Fofana DB, Soulie C, Maiga AI, Fourati S, Malet I, Wirden M, Tounkara A, Traore HA, Calvez V, Marcelin AG, Lambert-Niclot S. Fofana DB, et al. Among authors: wirden m. J Antimicrob Chemother. 2013 Nov;68(11):2515-20. doi: 10.1093/jac/dkt251. Epub 2013 Jul 5. J Antimicrob Chemother. 2013. PMID: 23833185

9

Efficacy of raltegravir switching strategies in HIV-infected patients with suppressed viraemia according to the genotypic sensitivity score.

Caby F, Schneider L, Blanc C, Soulié C, Tindel M, Peytavin G, Agher R, Valantin MA, Tubiana R, Wirden M, Calvez V, Marcelin AG, Katlama C. Caby F, et al. Among authors: wirden m. Infection. 2014 Apr;42(2):295-301. doi: 10.1007/s15010-013-0542-8. Epub 2013 Oct 24. Infection. 2014. PMID: 24155032

10

Rilpivirine, emtricitabine and tenofovir resistance in HIV-1-infected rilpivirine-naive patients failing antiretroviral therapy.

Lambert-Niclot S, Charpentier C, Storto A, Fofana D, Soulie C, Fourati S, Wirden M, Morand-Joubert L, Masquelier B, Flandre P, Calvez V, Descamps D, Marcelin AG. Lambert-Niclot S, et al. Among authors: wirden m. J Antimicrob Chemother. 2014 Apr;69(4):1086-9. doi: 10.1093/jac/dkt463. Epub 2013 Dec 2. J Antimicrob Chemother. 2014. PMID: 24302653

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters